21st Anglonordic Life Science Conference

Event timezone:

My timezone:

Over 100 of the largest and most active investors will be attending to meet exciting companies.

REGISTRATION NOW OPEN

Tickets

For R&D and Business Support Companies, and Investors with Funds

Apply to Pitch

Startup companies are invited to present 10 minute pitches to investors and potential collaborators

Sponsor or Exhibit

Sponsor the conference, or purchase exhibit space to promote your company and gain access to 1:1 partnering

WHY ATTEND?

On 3 April, 2025, over 400 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London for the 21st Annual Anglonordic Life Science Conference.

The Reception, our must-attend networking event, takes place the evening before at the London Institute for Healthcare Engineering.

The Conference will be attended by high quality investors, featuring on-point panel discussions around European investment and technologies, and 36 funding pitches presented by cutting-edge biomedical and healthcare startups. 1:1 partnering takes place throughout the day.

Check out this year's Programme

With the support of M Ventures as lead and founding sponsor, and the generosity of the London Institute for Healthcare Engineering in providing their venue for The Reception for the second time, this edition of Anglonordic is one of the top networking and partnering events, and the unique R&D-to-investor conference in the UK.

Conference begins in:

Keynote Speaker

Göran Ando MD, Chairman, Nouscom AG

Programme

The Reception

Kindly hosted by:

Charity of the Year

Find out more

400+ Attendees

Exclusively selected attendees represent the following key drivers of the European life sciences growth sector:

CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
Decision-makers from Europe's key Investor firms and Pharma companies
Key Supporters of the Life Science Ecosystem in Europe
Country delegations: hand-picked growth companies from global life science clusters

80+ Investor Firms

Anglonordic celebrates a 21-year tradition of attracting leading lifescience investment firms with funds.

We are expecting over 80 investment firms to attend. Based across Europe, these funders have interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.

View the list of investors who have already committed to attend.

36 Startup Pitches

High quality, investor-selected growth companies

Company pitches are selected by our investor panel from a broad set of applicants
We encourage biotech, medtech and technology startups to apply
Developing ground-breaking technologies, these companies will be seeking funding and/or collaborations
The current round of applications closes on Friday 21st February - apply here.

300+ Partnering Meetings

Networking and 1:1 meetings

Networking is high on the priority list for Anglonordic delegates. Business discussions start well ahead of the conference, via our networking and 1:1 meeting scheduling platform. The platform features rich company/investor profiling plus instant messaging. Over 1,000 meeting requests and 5,000 messages were sent last year.